Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating oral difelikefalin for moderate to severe pruritus in people with notalgia paresthetica has been terminated. The update does not in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Notalgia Paresthetica
• Pruritus

Drugs mentioned

• Difelikefalin (Korsuva) (difelikefalin)

Snippet

Sponsor: Cara Therapeutics, Inc. | Conditions: Pruritus, Notalgia Paresthetica | Phase 2, Phase 3 | Status: TERMINATED